When people struggle with anxiety and depression, the most effective approach is often to combine medication and ...

Please provide your email address to receive an email when new articles are posted on . High-definition transcranial direct current stimulation was well tolerated with mild adverse effects. The ...

Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe depression ...

Treatment with the psychedelic dimethyltryptamine, or DMT, alongside psychotherapy, can relieve severe depressive symptoms, a phase 2 trial has found.

A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients with serious depression did not provide a significant additional benefit.

A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being ...

In 2024, MUSC Health became the first hospital system to offer a revolutionary new depression treatment to patients, taking a successful innovation a leap further. Stanford Neuromodulation Therapy, or ...